COVID-19 Impact on Global Next Generation Cancer Diagnostic Devices, Market Insights and Forecast to 2026
Next Generation Cancer Diagnostic Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Next Generation Cancer Diagnostic Devices market is segmented into
The Next Generation Cancer Diagnostic Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Next Generation Cancer Diagnostic Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Next Generation Cancer Diagnostic Devices Market Share Analysis
Next Generation Cancer Diagnostic Devices market competitive landscape provides details and data information by manufacturers.
The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Next Generation Cancer Diagnostic Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Next Generation Cancer Diagnostic Devices business, the date to enter into the Next Generation Cancer Diagnostic Devices market, Next Generation Cancer Diagnostic Devices product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Next Generation Cancer Diagnostic Devices market is segmented into
- Next Generation Sequencing
- qPCR & Multiplexing
- Lab-on- a- chip (LOAC)
- Protein Microarrays
- DNA Microarrays
- Reverse Transcriptase-PCR (RT-PCR)
- Biomarker Development
- CTC Analysis
- Proteomic Analysis
- Epigenetic Analysis
- Genetic Analysis
The Next Generation Cancer Diagnostic Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Next Generation Cancer Diagnostic Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Next Generation Cancer Diagnostic Devices Market Share Analysis
Next Generation Cancer Diagnostic Devices market competitive landscape provides details and data information by manufacturers.
The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Next Generation Cancer Diagnostic Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Next Generation Cancer Diagnostic Devices business, the date to enter into the Next Generation Cancer Diagnostic Devices market, Next Generation Cancer Diagnostic Devices product introduction, recent developments, etc.
The major vendors covered:
- Roche Holding Ltd.?Switzerland)
- Abbott Laboratories(US)
- Siemens Healthcare(Germany)
- Agilent Technologies Inc(Germany)
- Illumina Inc.(US)
- Becton Dickinson and Co.(US)
- QIAGEN N.V.(Germany)
- Affymetrix Inc.(US)
- Johnson & Johnson(US)
- Thermo Fisher Scientific Inc.(US)
- GE Healthcare(England)
- Life Technologies Corp.(US)
- Luminex Corp.(US)
- Cepheid Inc.(US)
1 STUDY COVERAGE
1.1 Next Generation Cancer Diagnostic Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Type
1.4.2 Next Generation Sequencing
1.4.3 qPCR & Multiplexing
1.4.4 Lab-on- a- chip (LOAC)
1.4.5 Protein Microarrays
1.4.6 DNA Microarrays
1.4.7 Reverse Transcriptase-PCR (RT-PCR)
1.5 Market by Application
1.5.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Application
1.5.2 Biomarker Development
1.5.3 CTC Analysis
1.5.4 Proteomic Analysis
1.5.5 Epigenetic Analysis
1.5.6 Genetic Analysis
1.6 Coronavirus Disease 2019 (Covid-19): Next Generation Cancer Diagnostic Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Next Generation Cancer Diagnostic Devices Industry
1.6.1.1 Next Generation Cancer Diagnostic Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Next Generation Cancer Diagnostic Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Next Generation Cancer Diagnostic Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Next Generation Cancer Diagnostic Devices Market Size Estimates and Forecasts
2.1.1 Global Next Generation Cancer Diagnostic Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Next Generation Cancer Diagnostic Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Next Generation Cancer Diagnostic Devices Production Estimates and Forecasts 2015-2026
2.2 Global Next Generation Cancer Diagnostic Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Next Generation Cancer Diagnostic Devices Manufacturers Geographical Distribution
2.4 Key Trends for Next Generation Cancer Diagnostic Devices Markets & Products
2.5 Primary Interviews with Key Next Generation Cancer Diagnostic Devices Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Production Capacity
3.1.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Next Generation Cancer Diagnostic Devices Manufacturers Market Share by Production
3.2 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue
3.2.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Next Generation Cancer Diagnostic Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostic Devices Revenue in 2019
3.3 Global Next Generation Cancer Diagnostic Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 NEXT GENERATION CANCER DIAGNOSTIC DEVICES PRODUCTION BY REGIONS
4.1 Global Next Generation Cancer Diagnostic Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Next Generation Cancer Diagnostic Devices Regions by Production (2015-2020)
4.1.2 Global Top Next Generation Cancer Diagnostic Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Next Generation Cancer Diagnostic Devices Production (2015-2020)
4.2.2 North America Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Next Generation Cancer Diagnostic Devices Production (2015-2020)
4.3.2 Europe Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Next Generation Cancer Diagnostic Devices Production (2015-2020)
4.4.2 China Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Next Generation Cancer Diagnostic Devices Production (2015-2020)
4.5.2 Japan Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
5 NEXT GENERATION CANCER DIAGNOSTIC DEVICES CONSUMPTION BY REGION
5.1 Global Top Next Generation Cancer Diagnostic Devices Regions by Consumption
5.1.1 Global Top Next Generation Cancer Diagnostic Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Next Generation Cancer Diagnostic Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Next Generation Cancer Diagnostic Devices Consumption by Application
5.2.2 North America Next Generation Cancer Diagnostic Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Next Generation Cancer Diagnostic Devices Consumption by Application
5.3.2 Europe Next Generation Cancer Diagnostic Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Application
5.4.2 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Next Generation Cancer Diagnostic Devices Consumption by Application
5.5.2 Central & South America Next Generation Cancer Diagnostic Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Application
5.6.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Next Generation Cancer Diagnostic Devices Market Size by Type (2015-2020)
6.1.1 Global Next Generation Cancer Diagnostic Devices Production by Type (2015-2020)
6.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Type (2015-2020)
6.1.3 Next Generation Cancer Diagnostic Devices Price by Type (2015-2020)
6.2 Global Next Generation Cancer Diagnostic Devices Market Forecast by Type (2021-2026)
6.2.1 Global Next Generation Cancer Diagnostic Devices Production Forecast by Type (2021-2026)
6.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Type (2021-2026)
6.3 Global Next Generation Cancer Diagnostic Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Next Generation Cancer Diagnostic Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Next Generation Cancer Diagnostic Devices Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Roche Holding Ltd.?Switzerland)
8.1.1 Roche Holding Ltd.?Switzerland) Corporation Information
8.1.2 Roche Holding Ltd.?Switzerland) Overview and Its Total Revenue
8.1.3 Roche Holding Ltd.?Switzerland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Roche Holding Ltd.?Switzerland) Product Description
8.1.5 Roche Holding Ltd.?Switzerland) Recent Development
8.2 Abbott Laboratories(US)
8.2.1 Abbott Laboratories(US) Corporation Information
8.2.2 Abbott Laboratories(US) Overview and Its Total Revenue
8.2.3 Abbott Laboratories(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Abbott Laboratories(US) Product Description
8.2.5 Abbott Laboratories(US) Recent Development
8.3 Siemens Healthcare(Germany)
8.3.1 Siemens Healthcare(Germany) Corporation Information
8.3.2 Siemens Healthcare(Germany) Overview and Its Total Revenue
8.3.3 Siemens Healthcare(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Siemens Healthcare(Germany) Product Description
8.3.5 Siemens Healthcare(Germany) Recent Development
8.4 Agilent Technologies Inc(Germany)
8.4.1 Agilent Technologies Inc(Germany) Corporation Information
8.4.2 Agilent Technologies Inc(Germany) Overview and Its Total Revenue
8.4.3 Agilent Technologies Inc(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Agilent Technologies Inc(Germany) Product Description
8.4.5 Agilent Technologies Inc(Germany) Recent Development
8.5 Illumina Inc.(US)
8.5.1 Illumina Inc.(US) Corporation Information
8.5.2 Illumina Inc.(US) Overview and Its Total Revenue
8.5.3 Illumina Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Illumina Inc.(US) Product Description
8.5.5 Illumina Inc.(US) Recent Development
8.6 Becton Dickinson and Co.(US)
8.6.1 Becton Dickinson and Co.(US) Corporation Information
8.6.2 Becton Dickinson and Co.(US) Overview and Its Total Revenue
8.6.3 Becton Dickinson and Co.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Becton Dickinson and Co.(US) Product Description
8.6.5 Becton Dickinson and Co.(US) Recent Development
8.7 QIAGEN N.V.(Germany)
8.7.1 QIAGEN N.V.(Germany) Corporation Information
8.7.2 QIAGEN N.V.(Germany) Overview and Its Total Revenue
8.7.3 QIAGEN N.V.(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 QIAGEN N.V.(Germany) Product Description
8.7.5 QIAGEN N.V.(Germany) Recent Development
8.8 Affymetrix Inc.(US)
8.8.1 Affymetrix Inc.(US) Corporation Information
8.8.2 Affymetrix Inc.(US) Overview and Its Total Revenue
8.8.3 Affymetrix Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Affymetrix Inc.(US) Product Description
8.8.5 Affymetrix Inc.(US) Recent Development
8.9 Johnson & Johnson(US)
8.9.1 Johnson & Johnson(US) Corporation Information
8.9.2 Johnson & Johnson(US) Overview and Its Total Revenue
8.9.3 Johnson & Johnson(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Johnson & Johnson(US) Product Description
8.9.5 Johnson & Johnson(US) Recent Development
8.10 Thermo Fisher Scientific Inc.(US)
8.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
8.10.2 Thermo Fisher Scientific Inc.(US) Overview and Its Total Revenue
8.10.3 Thermo Fisher Scientific Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Thermo Fisher Scientific Inc.(US) Product Description
8.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
8.11 GE Healthcare(England)
8.11.1 GE Healthcare(England) Corporation Information
8.11.2 GE Healthcare(England) Overview and Its Total Revenue
8.11.3 GE Healthcare(England) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 GE Healthcare(England) Product Description
8.11.5 GE Healthcare(England) Recent Development
8.12 Life Technologies Corp.(US)
8.12.1 Life Technologies Corp.(US) Corporation Information
8.12.2 Life Technologies Corp.(US) Overview and Its Total Revenue
8.12.3 Life Technologies Corp.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Life Technologies Corp.(US) Product Description
8.12.5 Life Technologies Corp.(US) Recent Development
8.13 Luminex Corp.(US)
8.13.1 Luminex Corp.(US) Corporation Information
8.13.2 Luminex Corp.(US) Overview and Its Total Revenue
8.13.3 Luminex Corp.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Luminex Corp.(US) Product Description
8.13.5 Luminex Corp.(US) Recent Development
8.14 Cepheid Inc.(US)
8.14.1 Cepheid Inc.(US) Corporation Information
8.14.2 Cepheid Inc.(US) Overview and Its Total Revenue
8.14.3 Cepheid Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Cepheid Inc.(US) Product Description
8.14.5 Cepheid Inc.(US) Recent Development
8.15 Allegro Diagnostics Corp.(Brazil)
8.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
8.15.2 Allegro Diagnostics Corp.(Brazil) Overview and Its Total Revenue
8.15.3 Allegro Diagnostics Corp.(Brazil) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Allegro Diagnostics Corp.(Brazil) Product Description
8.15.5 Allegro Diagnostics Corp.(Brazil) Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Next Generation Cancer Diagnostic Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Next Generation Cancer Diagnostic Devices Regions Forecast by Production (2021-2026)
9.3 Key Next Generation Cancer Diagnostic Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 NEXT GENERATION CANCER DIAGNOSTIC DEVICES CONSUMPTION FORECAST BY REGION
10.1 Global Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.2 North America Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Next Generation Cancer Diagnostic Devices Sales Channels
11.2.2 Next Generation Cancer Diagnostic Devices Distributors
11.3 Next Generation Cancer Diagnostic Devices Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL NEXT GENERATION CANCER DIAGNOSTIC DEVICES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Next Generation Cancer Diagnostic Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Type
1.4.2 Next Generation Sequencing
1.4.3 qPCR & Multiplexing
1.4.4 Lab-on- a- chip (LOAC)
1.4.5 Protein Microarrays
1.4.6 DNA Microarrays
1.4.7 Reverse Transcriptase-PCR (RT-PCR)
1.5 Market by Application
1.5.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Application
1.5.2 Biomarker Development
1.5.3 CTC Analysis
1.5.4 Proteomic Analysis
1.5.5 Epigenetic Analysis
1.5.6 Genetic Analysis
1.6 Coronavirus Disease 2019 (Covid-19): Next Generation Cancer Diagnostic Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Next Generation Cancer Diagnostic Devices Industry
1.6.1.1 Next Generation Cancer Diagnostic Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Next Generation Cancer Diagnostic Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Next Generation Cancer Diagnostic Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Next Generation Cancer Diagnostic Devices Market Size Estimates and Forecasts
2.1.1 Global Next Generation Cancer Diagnostic Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Next Generation Cancer Diagnostic Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Next Generation Cancer Diagnostic Devices Production Estimates and Forecasts 2015-2026
2.2 Global Next Generation Cancer Diagnostic Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Next Generation Cancer Diagnostic Devices Manufacturers Geographical Distribution
2.4 Key Trends for Next Generation Cancer Diagnostic Devices Markets & Products
2.5 Primary Interviews with Key Next Generation Cancer Diagnostic Devices Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Production Capacity
3.1.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Next Generation Cancer Diagnostic Devices Manufacturers Market Share by Production
3.2 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue
3.2.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Next Generation Cancer Diagnostic Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostic Devices Revenue in 2019
3.3 Global Next Generation Cancer Diagnostic Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 NEXT GENERATION CANCER DIAGNOSTIC DEVICES PRODUCTION BY REGIONS
4.1 Global Next Generation Cancer Diagnostic Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Next Generation Cancer Diagnostic Devices Regions by Production (2015-2020)
4.1.2 Global Top Next Generation Cancer Diagnostic Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Next Generation Cancer Diagnostic Devices Production (2015-2020)
4.2.2 North America Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Next Generation Cancer Diagnostic Devices Production (2015-2020)
4.3.2 Europe Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Next Generation Cancer Diagnostic Devices Production (2015-2020)
4.4.2 China Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Next Generation Cancer Diagnostic Devices Production (2015-2020)
4.5.2 Japan Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
5 NEXT GENERATION CANCER DIAGNOSTIC DEVICES CONSUMPTION BY REGION
5.1 Global Top Next Generation Cancer Diagnostic Devices Regions by Consumption
5.1.1 Global Top Next Generation Cancer Diagnostic Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Next Generation Cancer Diagnostic Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Next Generation Cancer Diagnostic Devices Consumption by Application
5.2.2 North America Next Generation Cancer Diagnostic Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Next Generation Cancer Diagnostic Devices Consumption by Application
5.3.2 Europe Next Generation Cancer Diagnostic Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Application
5.4.2 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Next Generation Cancer Diagnostic Devices Consumption by Application
5.5.2 Central & South America Next Generation Cancer Diagnostic Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Application
5.6.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Next Generation Cancer Diagnostic Devices Market Size by Type (2015-2020)
6.1.1 Global Next Generation Cancer Diagnostic Devices Production by Type (2015-2020)
6.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Type (2015-2020)
6.1.3 Next Generation Cancer Diagnostic Devices Price by Type (2015-2020)
6.2 Global Next Generation Cancer Diagnostic Devices Market Forecast by Type (2021-2026)
6.2.1 Global Next Generation Cancer Diagnostic Devices Production Forecast by Type (2021-2026)
6.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Type (2021-2026)
6.3 Global Next Generation Cancer Diagnostic Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Next Generation Cancer Diagnostic Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Next Generation Cancer Diagnostic Devices Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Roche Holding Ltd.?Switzerland)
8.1.1 Roche Holding Ltd.?Switzerland) Corporation Information
8.1.2 Roche Holding Ltd.?Switzerland) Overview and Its Total Revenue
8.1.3 Roche Holding Ltd.?Switzerland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Roche Holding Ltd.?Switzerland) Product Description
8.1.5 Roche Holding Ltd.?Switzerland) Recent Development
8.2 Abbott Laboratories(US)
8.2.1 Abbott Laboratories(US) Corporation Information
8.2.2 Abbott Laboratories(US) Overview and Its Total Revenue
8.2.3 Abbott Laboratories(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Abbott Laboratories(US) Product Description
8.2.5 Abbott Laboratories(US) Recent Development
8.3 Siemens Healthcare(Germany)
8.3.1 Siemens Healthcare(Germany) Corporation Information
8.3.2 Siemens Healthcare(Germany) Overview and Its Total Revenue
8.3.3 Siemens Healthcare(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Siemens Healthcare(Germany) Product Description
8.3.5 Siemens Healthcare(Germany) Recent Development
8.4 Agilent Technologies Inc(Germany)
8.4.1 Agilent Technologies Inc(Germany) Corporation Information
8.4.2 Agilent Technologies Inc(Germany) Overview and Its Total Revenue
8.4.3 Agilent Technologies Inc(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Agilent Technologies Inc(Germany) Product Description
8.4.5 Agilent Technologies Inc(Germany) Recent Development
8.5 Illumina Inc.(US)
8.5.1 Illumina Inc.(US) Corporation Information
8.5.2 Illumina Inc.(US) Overview and Its Total Revenue
8.5.3 Illumina Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Illumina Inc.(US) Product Description
8.5.5 Illumina Inc.(US) Recent Development
8.6 Becton Dickinson and Co.(US)
8.6.1 Becton Dickinson and Co.(US) Corporation Information
8.6.2 Becton Dickinson and Co.(US) Overview and Its Total Revenue
8.6.3 Becton Dickinson and Co.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Becton Dickinson and Co.(US) Product Description
8.6.5 Becton Dickinson and Co.(US) Recent Development
8.7 QIAGEN N.V.(Germany)
8.7.1 QIAGEN N.V.(Germany) Corporation Information
8.7.2 QIAGEN N.V.(Germany) Overview and Its Total Revenue
8.7.3 QIAGEN N.V.(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 QIAGEN N.V.(Germany) Product Description
8.7.5 QIAGEN N.V.(Germany) Recent Development
8.8 Affymetrix Inc.(US)
8.8.1 Affymetrix Inc.(US) Corporation Information
8.8.2 Affymetrix Inc.(US) Overview and Its Total Revenue
8.8.3 Affymetrix Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Affymetrix Inc.(US) Product Description
8.8.5 Affymetrix Inc.(US) Recent Development
8.9 Johnson & Johnson(US)
8.9.1 Johnson & Johnson(US) Corporation Information
8.9.2 Johnson & Johnson(US) Overview and Its Total Revenue
8.9.3 Johnson & Johnson(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Johnson & Johnson(US) Product Description
8.9.5 Johnson & Johnson(US) Recent Development
8.10 Thermo Fisher Scientific Inc.(US)
8.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
8.10.2 Thermo Fisher Scientific Inc.(US) Overview and Its Total Revenue
8.10.3 Thermo Fisher Scientific Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Thermo Fisher Scientific Inc.(US) Product Description
8.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
8.11 GE Healthcare(England)
8.11.1 GE Healthcare(England) Corporation Information
8.11.2 GE Healthcare(England) Overview and Its Total Revenue
8.11.3 GE Healthcare(England) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 GE Healthcare(England) Product Description
8.11.5 GE Healthcare(England) Recent Development
8.12 Life Technologies Corp.(US)
8.12.1 Life Technologies Corp.(US) Corporation Information
8.12.2 Life Technologies Corp.(US) Overview and Its Total Revenue
8.12.3 Life Technologies Corp.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Life Technologies Corp.(US) Product Description
8.12.5 Life Technologies Corp.(US) Recent Development
8.13 Luminex Corp.(US)
8.13.1 Luminex Corp.(US) Corporation Information
8.13.2 Luminex Corp.(US) Overview and Its Total Revenue
8.13.3 Luminex Corp.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Luminex Corp.(US) Product Description
8.13.5 Luminex Corp.(US) Recent Development
8.14 Cepheid Inc.(US)
8.14.1 Cepheid Inc.(US) Corporation Information
8.14.2 Cepheid Inc.(US) Overview and Its Total Revenue
8.14.3 Cepheid Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Cepheid Inc.(US) Product Description
8.14.5 Cepheid Inc.(US) Recent Development
8.15 Allegro Diagnostics Corp.(Brazil)
8.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
8.15.2 Allegro Diagnostics Corp.(Brazil) Overview and Its Total Revenue
8.15.3 Allegro Diagnostics Corp.(Brazil) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Allegro Diagnostics Corp.(Brazil) Product Description
8.15.5 Allegro Diagnostics Corp.(Brazil) Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Next Generation Cancer Diagnostic Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Next Generation Cancer Diagnostic Devices Regions Forecast by Production (2021-2026)
9.3 Key Next Generation Cancer Diagnostic Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 NEXT GENERATION CANCER DIAGNOSTIC DEVICES CONSUMPTION FORECAST BY REGION
10.1 Global Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.2 North America Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Next Generation Cancer Diagnostic Devices Sales Channels
11.2.2 Next Generation Cancer Diagnostic Devices Distributors
11.3 Next Generation Cancer Diagnostic Devices Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL NEXT GENERATION CANCER DIAGNOSTIC DEVICES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Next Generation Cancer Diagnostic Devices Key Market Segments in This Study
Table 2. Ranking of Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Type 2020-2026 (K Pcs) (Million US$)
Table 4. Major Manufacturers of Next Generation Sequencing
Table 5. Major Manufacturers of qPCR & Multiplexing
Table 6. Major Manufacturers of Lab-on- a- chip (LOAC)
Table 7. Major Manufacturers of Protein Microarrays
Table 8. Major Manufacturers of DNA Microarrays
Table 9. Major Manufacturers of Reverse Transcriptase-PCR (RT-PCR)
Table 10. COVID-19 Impact Global Market: (Four Next Generation Cancer Diagnostic Devices Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Next Generation Cancer Diagnostic Devices Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Next Generation Cancer Diagnostic Devices Players to Combat Covid-19 Impact
Table 15. Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 16. Global Next Generation Cancer Diagnostic Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 17. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Next Generation Cancer Diagnostic Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2019)
Table 19. Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Next Generation Cancer Diagnostic Devices Product Offered
Table 21. Date of Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
Table 22. Key Trends for Next Generation Cancer Diagnostic Devices Markets & Products
Table 23. Main Points Interviewed from Key Next Generation Cancer Diagnostic Devices Players
Table 24. Global Next Generation Cancer Diagnostic Devices Production Capacity by Manufacturers (2015-2020) (K Pcs)
Table 25. Global Next Generation Cancer Diagnostic Devices Production Share by Manufacturers (2015-2020)
Table 26. Next Generation Cancer Diagnostic Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 27. Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2015-2020)
Table 28. Next Generation Cancer Diagnostic Devices Price by Manufacturers 2015-2020 (USD/Pcs)
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Next Generation Cancer Diagnostic Devices Production by Regions (2015-2020) (K Pcs)
Table 31. Global Next Generation Cancer Diagnostic Devices Production Market Share by Regions (2015-2020)
Table 32. Global Next Generation Cancer Diagnostic Devices Revenue by Regions (2015-2020) (US$ Million)
Table 33. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions (2015-2020)
Table 34. Key Next Generation Cancer Diagnostic Devices Players in North America
Table 35. Import & Export of Next Generation Cancer Diagnostic Devices in North America (K Pcs)
Table 36. Key Next Generation Cancer Diagnostic Devices Players in Europe
Table 37. Import & Export of Next Generation Cancer Diagnostic Devices in Europe (K Pcs)
Table 38. Key Next Generation Cancer Diagnostic Devices Players in China
Table 39. Import & Export of Next Generation Cancer Diagnostic Devices in China (K Pcs)
Table 40. Key Next Generation Cancer Diagnostic Devices Players in Japan
Table 41. Import & Export of Next Generation Cancer Diagnostic Devices in Japan (K Pcs)
Table 42. Global Next Generation Cancer Diagnostic Devices Consumption by Regions (2015-2020) (K Pcs)
Table 43. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Regions (2015-2020)
Table 44. North America Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 45. North America Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)
Table 46. Europe Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 47. Europe Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)
Table 48. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 49. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Market Share by Application (2015-2020) (K Pcs)
Table 50. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Regions (2015-2020) (K Pcs)
Table 51. Latin America Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 52. Latin America Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)
Table 53. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 54. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)
Table 55. Global Next Generation Cancer Diagnostic Devices Production by Type (2015-2020) (K Pcs)
Table 56. Global Next Generation Cancer Diagnostic Devices Production Share by Type (2015-2020)
Table 57. Global Next Generation Cancer Diagnostic Devices Revenue by Type (2015-2020) (Million US$)
Table 58. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2015-2020)
Table 59. Next Generation Cancer Diagnostic Devices Price by Type 2015-2020 (USD/Pcs)
Table 60. Global Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 61. Global Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 62. Global Next Generation Cancer Diagnostic Devices Consumption Share by Application (2015-2020)
Table 63. Roche Holding Ltd.?Switzerland) Corporation Information
Table 64. Roche Holding Ltd.?Switzerland) Description and Major Businesses
Table 65. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 66. Roche Holding Ltd.?Switzerland) Product
Table 67. Roche Holding Ltd.?Switzerland) Recent Development
Table 68. Abbott Laboratories(US) Corporation Information
Table 69. Abbott Laboratories(US) Description and Major Businesses
Table 70. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 71. Abbott Laboratories(US) Product
Table 72. Abbott Laboratories(US) Recent Development
Table 73. Siemens Healthcare(Germany) Corporation Information
Table 74. Siemens Healthcare(Germany) Description and Major Businesses
Table 75. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Siemens Healthcare(Germany) Product
Table 77. Siemens Healthcare(Germany) Recent Development
Table 78. Agilent Technologies Inc(Germany) Corporation Information
Table 79. Agilent Technologies Inc(Germany) Description and Major Businesses
Table 80. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Agilent Technologies Inc(Germany) Product
Table 82. Agilent Technologies Inc(Germany) Recent Development
Table 83. Illumina Inc.(US) Corporation Information
Table 84. Illumina Inc.(US) Description and Major Businesses
Table 85. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Illumina Inc.(US) Product
Table 87. Illumina Inc.(US) Recent Development
Table 88. Becton Dickinson and Co.(US) Corporation Information
Table 89. Becton Dickinson and Co.(US) Description and Major Businesses
Table 90. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Becton Dickinson and Co.(US) Product
Table 92. Becton Dickinson and Co.(US) Recent Development
Table 93. QIAGEN N.V.(Germany) Corporation Information
Table 94. QIAGEN N.V.(Germany) Description and Major Businesses
Table 95. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. QIAGEN N.V.(Germany) Product
Table 97. QIAGEN N.V.(Germany) Recent Development
Table 98. Affymetrix Inc.(US) Corporation Information
Table 99. Affymetrix Inc.(US) Description and Major Businesses
Table 100. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Affymetrix Inc.(US) Product
Table 102. Affymetrix Inc.(US) Recent Development
Table 103. Johnson & Johnson(US) Corporation Information
Table 104. Johnson & Johnson(US) Description and Major Businesses
Table 105. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Johnson & Johnson(US) Product
Table 107. Johnson & Johnson(US) Recent Development
Table 108. Thermo Fisher Scientific Inc.(US) Corporation Information
Table 109. Thermo Fisher Scientific Inc.(US) Description and Major Businesses
Table 110. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Thermo Fisher Scientific Inc.(US) Product
Table 112. Thermo Fisher Scientific Inc.(US) Recent Development
Table 113. GE Healthcare(England) Corporation Information
Table 114. GE Healthcare(England) Description and Major Businesses
Table 115. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. GE Healthcare(England) Product
Table 117. GE Healthcare(England) Recent Development
Table 118. Life Technologies Corp.(US) Corporation Information
Table 119. Life Technologies Corp.(US) Description and Major Businesses
Table 120. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Life Technologies Corp.(US) Product
Table 122. Life Technologies Corp.(US) Recent Development
Table 123. Luminex Corp.(US) Corporation Information
Table 124. Luminex Corp.(US) Description and Major Businesses
Table 125. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Luminex Corp.(US) Product
Table 127. Luminex Corp.(US) Recent Development
Table 128. Cepheid Inc.(US) Corporation Information
Table 129. Cepheid Inc.(US) Description and Major Businesses
Table 130. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Cepheid Inc.(US) Product
Table 132. Cepheid Inc.(US) Recent Development
Table 133. Allegro Diagnostics Corp.(Brazil) Corporation Information
Table 134. Allegro Diagnostics Corp.(Brazil) Description and Major Businesses
Table 135. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Allegro Diagnostics Corp.(Brazil) Product
Table 137. Allegro Diagnostics Corp.(Brazil) Recent Development
Table 138. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 139. Global Next Generation Cancer Diagnostic Devices Production Forecast by Regions (2021-2026) (K Pcs)
Table 140. Global Next Generation Cancer Diagnostic Devices Production Forecast by Type (2021-2026) (K Pcs)
Table 141. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 142. North America Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 143. Europe Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 144. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 145. Latin America Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 146. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 147. Next Generation Cancer Diagnostic Devices Distributors List
Table 148. Next Generation Cancer Diagnostic Devices Customers List
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
Table 1. Next Generation Cancer Diagnostic Devices Key Market Segments in This Study
Table 2. Ranking of Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Type 2020-2026 (K Pcs) (Million US$)
Table 4. Major Manufacturers of Next Generation Sequencing
Table 5. Major Manufacturers of qPCR & Multiplexing
Table 6. Major Manufacturers of Lab-on- a- chip (LOAC)
Table 7. Major Manufacturers of Protein Microarrays
Table 8. Major Manufacturers of DNA Microarrays
Table 9. Major Manufacturers of Reverse Transcriptase-PCR (RT-PCR)
Table 10. COVID-19 Impact Global Market: (Four Next Generation Cancer Diagnostic Devices Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Next Generation Cancer Diagnostic Devices Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Next Generation Cancer Diagnostic Devices Players to Combat Covid-19 Impact
Table 15. Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 16. Global Next Generation Cancer Diagnostic Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 17. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Next Generation Cancer Diagnostic Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2019)
Table 19. Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Next Generation Cancer Diagnostic Devices Product Offered
Table 21. Date of Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
Table 22. Key Trends for Next Generation Cancer Diagnostic Devices Markets & Products
Table 23. Main Points Interviewed from Key Next Generation Cancer Diagnostic Devices Players
Table 24. Global Next Generation Cancer Diagnostic Devices Production Capacity by Manufacturers (2015-2020) (K Pcs)
Table 25. Global Next Generation Cancer Diagnostic Devices Production Share by Manufacturers (2015-2020)
Table 26. Next Generation Cancer Diagnostic Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 27. Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2015-2020)
Table 28. Next Generation Cancer Diagnostic Devices Price by Manufacturers 2015-2020 (USD/Pcs)
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Next Generation Cancer Diagnostic Devices Production by Regions (2015-2020) (K Pcs)
Table 31. Global Next Generation Cancer Diagnostic Devices Production Market Share by Regions (2015-2020)
Table 32. Global Next Generation Cancer Diagnostic Devices Revenue by Regions (2015-2020) (US$ Million)
Table 33. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions (2015-2020)
Table 34. Key Next Generation Cancer Diagnostic Devices Players in North America
Table 35. Import & Export of Next Generation Cancer Diagnostic Devices in North America (K Pcs)
Table 36. Key Next Generation Cancer Diagnostic Devices Players in Europe
Table 37. Import & Export of Next Generation Cancer Diagnostic Devices in Europe (K Pcs)
Table 38. Key Next Generation Cancer Diagnostic Devices Players in China
Table 39. Import & Export of Next Generation Cancer Diagnostic Devices in China (K Pcs)
Table 40. Key Next Generation Cancer Diagnostic Devices Players in Japan
Table 41. Import & Export of Next Generation Cancer Diagnostic Devices in Japan (K Pcs)
Table 42. Global Next Generation Cancer Diagnostic Devices Consumption by Regions (2015-2020) (K Pcs)
Table 43. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Regions (2015-2020)
Table 44. North America Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 45. North America Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)
Table 46. Europe Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 47. Europe Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)
Table 48. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 49. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Market Share by Application (2015-2020) (K Pcs)
Table 50. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Regions (2015-2020) (K Pcs)
Table 51. Latin America Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 52. Latin America Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)
Table 53. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 54. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)
Table 55. Global Next Generation Cancer Diagnostic Devices Production by Type (2015-2020) (K Pcs)
Table 56. Global Next Generation Cancer Diagnostic Devices Production Share by Type (2015-2020)
Table 57. Global Next Generation Cancer Diagnostic Devices Revenue by Type (2015-2020) (Million US$)
Table 58. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2015-2020)
Table 59. Next Generation Cancer Diagnostic Devices Price by Type 2015-2020 (USD/Pcs)
Table 60. Global Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 61. Global Next Generation Cancer Diagnostic Devices Consumption by Application (2015-2020) (K Pcs)
Table 62. Global Next Generation Cancer Diagnostic Devices Consumption Share by Application (2015-2020)
Table 63. Roche Holding Ltd.?Switzerland) Corporation Information
Table 64. Roche Holding Ltd.?Switzerland) Description and Major Businesses
Table 65. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 66. Roche Holding Ltd.?Switzerland) Product
Table 67. Roche Holding Ltd.?Switzerland) Recent Development
Table 68. Abbott Laboratories(US) Corporation Information
Table 69. Abbott Laboratories(US) Description and Major Businesses
Table 70. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 71. Abbott Laboratories(US) Product
Table 72. Abbott Laboratories(US) Recent Development
Table 73. Siemens Healthcare(Germany) Corporation Information
Table 74. Siemens Healthcare(Germany) Description and Major Businesses
Table 75. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Siemens Healthcare(Germany) Product
Table 77. Siemens Healthcare(Germany) Recent Development
Table 78. Agilent Technologies Inc(Germany) Corporation Information
Table 79. Agilent Technologies Inc(Germany) Description and Major Businesses
Table 80. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Agilent Technologies Inc(Germany) Product
Table 82. Agilent Technologies Inc(Germany) Recent Development
Table 83. Illumina Inc.(US) Corporation Information
Table 84. Illumina Inc.(US) Description and Major Businesses
Table 85. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Illumina Inc.(US) Product
Table 87. Illumina Inc.(US) Recent Development
Table 88. Becton Dickinson and Co.(US) Corporation Information
Table 89. Becton Dickinson and Co.(US) Description and Major Businesses
Table 90. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Becton Dickinson and Co.(US) Product
Table 92. Becton Dickinson and Co.(US) Recent Development
Table 93. QIAGEN N.V.(Germany) Corporation Information
Table 94. QIAGEN N.V.(Germany) Description and Major Businesses
Table 95. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. QIAGEN N.V.(Germany) Product
Table 97. QIAGEN N.V.(Germany) Recent Development
Table 98. Affymetrix Inc.(US) Corporation Information
Table 99. Affymetrix Inc.(US) Description and Major Businesses
Table 100. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Affymetrix Inc.(US) Product
Table 102. Affymetrix Inc.(US) Recent Development
Table 103. Johnson & Johnson(US) Corporation Information
Table 104. Johnson & Johnson(US) Description and Major Businesses
Table 105. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Johnson & Johnson(US) Product
Table 107. Johnson & Johnson(US) Recent Development
Table 108. Thermo Fisher Scientific Inc.(US) Corporation Information
Table 109. Thermo Fisher Scientific Inc.(US) Description and Major Businesses
Table 110. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Thermo Fisher Scientific Inc.(US) Product
Table 112. Thermo Fisher Scientific Inc.(US) Recent Development
Table 113. GE Healthcare(England) Corporation Information
Table 114. GE Healthcare(England) Description and Major Businesses
Table 115. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. GE Healthcare(England) Product
Table 117. GE Healthcare(England) Recent Development
Table 118. Life Technologies Corp.(US) Corporation Information
Table 119. Life Technologies Corp.(US) Description and Major Businesses
Table 120. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Life Technologies Corp.(US) Product
Table 122. Life Technologies Corp.(US) Recent Development
Table 123. Luminex Corp.(US) Corporation Information
Table 124. Luminex Corp.(US) Description and Major Businesses
Table 125. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Luminex Corp.(US) Product
Table 127. Luminex Corp.(US) Recent Development
Table 128. Cepheid Inc.(US) Corporation Information
Table 129. Cepheid Inc.(US) Description and Major Businesses
Table 130. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Cepheid Inc.(US) Product
Table 132. Cepheid Inc.(US) Recent Development
Table 133. Allegro Diagnostics Corp.(Brazil) Corporation Information
Table 134. Allegro Diagnostics Corp.(Brazil) Description and Major Businesses
Table 135. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Allegro Diagnostics Corp.(Brazil) Product
Table 137. Allegro Diagnostics Corp.(Brazil) Recent Development
Table 138. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 139. Global Next Generation Cancer Diagnostic Devices Production Forecast by Regions (2021-2026) (K Pcs)
Table 140. Global Next Generation Cancer Diagnostic Devices Production Forecast by Type (2021-2026) (K Pcs)
Table 141. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 142. North America Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 143. Europe Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 144. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 145. Latin America Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 146. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 147. Next Generation Cancer Diagnostic Devices Distributors List
Table 148. Next Generation Cancer Diagnostic Devices Customers List
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Next Generation Cancer Diagnostic Devices Product Picture
Figure 2. Global Next Generation Cancer Diagnostic Devices Production Market Share by Type in 2020 & 2026
Figure 3. Next Generation Sequencing Product Picture
Figure 4. qPCR & Multiplexing Product Picture
Figure 5. Lab-on- a- chip (LOAC) Product Picture
Figure 6. Protein Microarrays Product Picture
Figure 7. DNA Microarrays Product Picture
Figure 8. Reverse Transcriptase-PCR (RT-PCR) Product Picture
Figure 9. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2020 & 2026
Figure 10. Biomarker Development
Figure 11. CTC Analysis
Figure 12. Proteomic Analysis
Figure 13. Epigenetic Analysis
Figure 14. Genetic Analysis
Figure 15. Next Generation Cancer Diagnostic Devices Report Years Considered
Figure 16. Global Next Generation Cancer Diagnostic Devices Revenue 2015-2026 (Million US$)
Figure 17. Global Next Generation Cancer Diagnostic Devices Production Capacity 2015-2026 (K Pcs)
Figure 18. Global Next Generation Cancer Diagnostic Devices Production 2015-2026 (K Pcs)
Figure 19. Global Next Generation Cancer Diagnostic Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 20. Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Next Generation Cancer Diagnostic Devices Production Share by Manufacturers in 2015
Figure 22. The Top 10 and Top 5 Players Market Share by Next Generation Cancer Diagnostic Devices Revenue in 2019
Figure 23. Global Next Generation Cancer Diagnostic Devices Production Market Share by Region (2015-2020)
Figure 24. Next Generation Cancer Diagnostic Devices Production Growth Rate in North America (2015-2020) (K Pcs)
Figure 25. Next Generation Cancer Diagnostic Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 26. Next Generation Cancer Diagnostic Devices Production Growth Rate in Europe (2015-2020) (K Pcs)
Figure 27. Next Generation Cancer Diagnostic Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 28. Next Generation Cancer Diagnostic Devices Production Growth Rate in China (2015-2020) (K Pcs)
Figure 29. Next Generation Cancer Diagnostic Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 30. Next Generation Cancer Diagnostic Devices Production Growth Rate in Japan (2015-2020) (K Pcs)
Figure 31. Next Generation Cancer Diagnostic Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 32. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Regions 2015-2020
Figure 33. North America Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 34. North America Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 35. North America Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019
Figure 36. U.S. Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 38. Europe Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 39. Europe Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 40. Europe Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019
Figure 41. Germany Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 42. France Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 43. U.K. Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 44. Italy Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 45. Russia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 46. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (K Pcs)
Figure 47. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 48. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Market Share by Regions in 2019
Figure 49. China Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 50. Japan Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 51. South Korea Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 52. India Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 53. Australia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 54. Taiwan Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 55. Indonesia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 56. Thailand Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 57. Malaysia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 58. Philippines Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 59. Vietnam Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 60. Latin America Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (K Pcs)
Figure 61. Latin America Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 62. Latin America Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019
Figure 63. Mexico Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 64. Brazil Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 65. Argentina Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 66. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (K Pcs)
Figure 67. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 68. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019
Figure 69. Turkey Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 70. Saudi Arabia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 71. U.A.E Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 72. Global Next Generation Cancer Diagnostic Devices Production Market Share by Type (2015-2020)
Figure 73. Global Next Generation Cancer Diagnostic Devices Production Market Share by Type in 2019
Figure 74. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2015-2020)
Figure 75. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type in 2019
Figure 76. Global Next Generation Cancer Diagnostic Devices Production Market Share Forecast by Type (2021-2026)
Figure 77. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 78. Global Next Generation Cancer Diagnostic Devices Market Share by Price Range (2015-2020)
Figure 79. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application (2015-2020)
Figure 80. Global Next Generation Cancer Diagnostic Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 81. Global Next Generation Cancer Diagnostic Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 82. Roche Holding Ltd.?Switzerland) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Abbott Laboratories(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Siemens Healthcare(Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Agilent Technologies Inc(Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Illumina Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Becton Dickinson and Co.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. QIAGEN N.V.(Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Affymetrix Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Johnson & Johnson(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Thermo Fisher Scientific Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. GE Healthcare(England) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Life Technologies Corp.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Luminex Corp.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Cepheid Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Allegro Diagnostics Corp.(Brazil) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 98. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Regions ((2021-2026))
Figure 99. Global Next Generation Cancer Diagnostic Devices Production Forecast by Regions (2021-2026) (K Pcs)
Figure 100. North America Next Generation Cancer Diagnostic Devices Production Forecast (2021-2026) (K Pcs)
Figure 101. North America Next Generation Cancer Diagnostic Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 102. Europe Next Generation Cancer Diagnostic Devices Production Forecast (2021-2026) (K Pcs)
Figure 103. Europe Next Generation Cancer Diagnostic Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 104. China Next Generation Cancer Diagnostic Devices Production Forecast (2021-2026) (K Pcs)
Figure 105. China Next Generation Cancer Diagnostic Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 106. Japan Next Generation Cancer Diagnostic Devices Production Forecast (2021-2026) (K Pcs)
Figure 107. Japan Next Generation Cancer Diagnostic Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 108. Global Next Generation Cancer Diagnostic Devices Consumption Market Share Forecast by Region (2021-2026)
Figure 109. Next Generation Cancer Diagnostic Devices Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
Figure 1. Next Generation Cancer Diagnostic Devices Product Picture
Figure 2. Global Next Generation Cancer Diagnostic Devices Production Market Share by Type in 2020 & 2026
Figure 3. Next Generation Sequencing Product Picture
Figure 4. qPCR & Multiplexing Product Picture
Figure 5. Lab-on- a- chip (LOAC) Product Picture
Figure 6. Protein Microarrays Product Picture
Figure 7. DNA Microarrays Product Picture
Figure 8. Reverse Transcriptase-PCR (RT-PCR) Product Picture
Figure 9. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2020 & 2026
Figure 10. Biomarker Development
Figure 11. CTC Analysis
Figure 12. Proteomic Analysis
Figure 13. Epigenetic Analysis
Figure 14. Genetic Analysis
Figure 15. Next Generation Cancer Diagnostic Devices Report Years Considered
Figure 16. Global Next Generation Cancer Diagnostic Devices Revenue 2015-2026 (Million US$)
Figure 17. Global Next Generation Cancer Diagnostic Devices Production Capacity 2015-2026 (K Pcs)
Figure 18. Global Next Generation Cancer Diagnostic Devices Production 2015-2026 (K Pcs)
Figure 19. Global Next Generation Cancer Diagnostic Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 20. Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Next Generation Cancer Diagnostic Devices Production Share by Manufacturers in 2015
Figure 22. The Top 10 and Top 5 Players Market Share by Next Generation Cancer Diagnostic Devices Revenue in 2019
Figure 23. Global Next Generation Cancer Diagnostic Devices Production Market Share by Region (2015-2020)
Figure 24. Next Generation Cancer Diagnostic Devices Production Growth Rate in North America (2015-2020) (K Pcs)
Figure 25. Next Generation Cancer Diagnostic Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 26. Next Generation Cancer Diagnostic Devices Production Growth Rate in Europe (2015-2020) (K Pcs)
Figure 27. Next Generation Cancer Diagnostic Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 28. Next Generation Cancer Diagnostic Devices Production Growth Rate in China (2015-2020) (K Pcs)
Figure 29. Next Generation Cancer Diagnostic Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 30. Next Generation Cancer Diagnostic Devices Production Growth Rate in Japan (2015-2020) (K Pcs)
Figure 31. Next Generation Cancer Diagnostic Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 32. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Regions 2015-2020
Figure 33. North America Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 34. North America Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 35. North America Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019
Figure 36. U.S. Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 38. Europe Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 39. Europe Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 40. Europe Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019
Figure 41. Germany Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 42. France Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 43. U.K. Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 44. Italy Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 45. Russia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 46. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (K Pcs)
Figure 47. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 48. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Market Share by Regions in 2019
Figure 49. China Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 50. Japan Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 51. South Korea Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 52. India Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 53. Australia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 54. Taiwan Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 55. Indonesia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 56. Thailand Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 57. Malaysia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 58. Philippines Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 59. Vietnam Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 60. Latin America Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (K Pcs)
Figure 61. Latin America Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 62. Latin America Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019
Figure 63. Mexico Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 64. Brazil Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 65. Argentina Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 66. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (K Pcs)
Figure 67. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019
Figure 68. Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019
Figure 69. Turkey Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 70. Saudi Arabia Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 71. U.A.E Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 72. Global Next Generation Cancer Diagnostic Devices Production Market Share by Type (2015-2020)
Figure 73. Global Next Generation Cancer Diagnostic Devices Production Market Share by Type in 2019
Figure 74. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2015-2020)
Figure 75. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type in 2019
Figure 76. Global Next Generation Cancer Diagnostic Devices Production Market Share Forecast by Type (2021-2026)
Figure 77. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 78. Global Next Generation Cancer Diagnostic Devices Market Share by Price Range (2015-2020)
Figure 79. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application (2015-2020)
Figure 80. Global Next Generation Cancer Diagnostic Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 81. Global Next Generation Cancer Diagnostic Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 82. Roche Holding Ltd.?Switzerland) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Abbott Laboratories(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Siemens Healthcare(Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Agilent Technologies Inc(Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Illumina Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Becton Dickinson and Co.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. QIAGEN N.V.(Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Affymetrix Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Johnson & Johnson(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Thermo Fisher Scientific Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. GE Healthcare(England) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Life Technologies Corp.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Luminex Corp.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Cepheid Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Allegro Diagnostics Corp.(Brazil) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 98. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Regions ((2021-2026))
Figure 99. Global Next Generation Cancer Diagnostic Devices Production Forecast by Regions (2021-2026) (K Pcs)
Figure 100. North America Next Generation Cancer Diagnostic Devices Production Forecast (2021-2026) (K Pcs)
Figure 101. North America Next Generation Cancer Diagnostic Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 102. Europe Next Generation Cancer Diagnostic Devices Production Forecast (2021-2026) (K Pcs)
Figure 103. Europe Next Generation Cancer Diagnostic Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 104. China Next Generation Cancer Diagnostic Devices Production Forecast (2021-2026) (K Pcs)
Figure 105. China Next Generation Cancer Diagnostic Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 106. Japan Next Generation Cancer Diagnostic Devices Production Forecast (2021-2026) (K Pcs)
Figure 107. Japan Next Generation Cancer Diagnostic Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 108. Global Next Generation Cancer Diagnostic Devices Consumption Market Share Forecast by Region (2021-2026)
Figure 109. Next Generation Cancer Diagnostic Devices Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
